News
TEM
47.85
-5.88%
-2.99
Weekly Report: what happened at TEM last week (0615-0619)?
Weekly Report · 15h ago
Can Tempus AI’s (TEM) New ECG-AF Validation Deepen Its Edge in Clinical-Grade Healthcare AI?
Simply Wall St · 1d ago
Tempus AI (TEM) Stock Could Be 22.9% Undervalued After ECG AF Validation
Simply Wall St · 3d ago
ARKK, HOOD, TEM, CRSP: ETF Inflow Alert
NASDAQ · 6d ago
Weekly Report: what happened at TEM last week (0608-0612)?
Weekly Report · 06/15 09:27
New FDA Clearances for Genomics and Cardiac AI Could Be A Game Changer For Tempus AI (TEM)
Simply Wall St · 06/13 07:30
Caris Life Sciences: The Discount To Peers Looks Hard To Ignore
Seeking Alpha · 06/12 11:57
Is It Time To Reassess Tempus AI (TEM) After Recent Share Price Volatility?
Simply Wall St · 06/11 22:29
Tempus AI: AI Precision Medicine With A Moat
Seeking Alpha · 06/11 15:32
Tempus AI Announces Publication Of A Successful Multi-Site Software Validation
Benzinga · 06/11 12:38
Tempus AI announces publication of multi-center validation of software
TipRanks · 06/11 12:35
Tempus AI says multi-center study validates FDA-cleared ECG model predicting 1-year atrial fibrillation risk
PUBT · 06/11 12:30
Tempus AI (TEM) Valuation Check As FDA Approval And New AI Tools Shape Growth Expectations
Simply Wall St · 06/10 08:28
Tempus AI: The Compression Has Outrun The Business - Upgrading To Buy
Seeking Alpha · 06/09 11:38
Tempus AI: A Unique AI Business Model With Asymmetric Upside
Seeking Alpha · 06/09 10:36
Ambry Study Shows RNA Testing May Clarify Uncertain Genetic Results
Benzinga · 06/09 10:07
Tempus unit Ambry study finds ExomeReveal RNA testing boosts clarity for uncertain exome results
PUBT · 06/09 10:00
Genetics in Medicine Open Study Demonstrates How Ambry Genetics’ ExomeReveal® RNA Testing Can Improve Diagnostic Clarity in Exome Testing
Barchart · 06/09 05:00
Great News: This Explosive Healthcare Stock Could Be a Powerful Artificial Intelligence Winner
The Motley Fool · 06/08 18:50
Weekly Report: what happened at TEM last week (0601-0605)?
Weekly Report · 06/08 09:26
More
Webull provides a variety of real-time TEM stock news. You can receive the latest news about Tempus AI through multiple platforms. This information may help you make smarter investment decisions.
About TEM
Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.